Bed Bath & Beyond (NASDAQ:BBBY) Price Target Cut to $13.00

Bed Bath & Beyond (NASDAQ:BBBY) had its price target reduced by research analysts at Morgan Stanley from $20.00 to $13.00 in a research note issued to investors on Friday, BenzingaRatingsTable reports. The brokerage presently has an “equal weight” rating on the retailer’s stock. Morgan Stanley’s price objective indicates a potential upside of 19.38% from the stock’s current price.

A number of other research analysts have also recently issued reports on BBBY. Wedbush lifted their price objective on shares of Columbia Sportswear from $111.00 to $113.00 and gave the company an “outperform” rating in a report on Thursday, April 11th. Robert W. Baird reduced their price objective on shares of Bed Bath & Beyond from $18.00 to $13.00 and set a “neutral” rating for the company in a report on Thursday. Deutsche Bank lifted their price objective on shares of Bed Bath & Beyond from $15.00 to $19.00 and gave the company a “hold” rating in a report on Thursday, April 11th. Wells Fargo & Co reiterated a “sell” rating on shares of American States Water in a report on Tuesday, March 26th. Finally, Raymond James reiterated a “hold” rating on shares of Apple in a report on Tuesday, March 26th. Six equities research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company. Bed Bath & Beyond currently has an average rating of “Hold” and a consensus target price of $15.55.

NASDAQ:BBBY opened at $10.89 on Friday. The company has a debt-to-equity ratio of 1.58, a current ratio of 1.52 and a quick ratio of 0.62. The firm has a market capitalization of $1.43 billion, a PE ratio of 5.31, a price-to-earnings-growth ratio of 5.91 and a beta of 1.19. The business has a fifty day moving average of $12.11. Bed Bath & Beyond has a 12 month low of $10.43 and a 12 month high of $20.38.



Bed Bath & Beyond (NASDAQ:BBBY) last posted its quarterly earnings results on Wednesday, July 10th. The retailer reported $0.12 EPS for the quarter, topping analysts’ consensus estimates of $0.08 by $0.04. The business had revenue of $2.57 billion during the quarter, compared to analysts’ expectations of $2.58 billion. Bed Bath & Beyond had a negative net margin of 4.66% and a positive return on equity of 9.49%. The business’s quarterly revenue was down 6.6% on a year-over-year basis. During the same period last year, the company posted $0.32 earnings per share. On average, research analysts forecast that Bed Bath & Beyond will post 1.89 EPS for the current year.

Institutional investors have recently added to or reduced their stakes in the stock. Investors Research Corp purchased a new position in Bed Bath & Beyond during the first quarter worth about $27,000. Motco purchased a new position in Bed Bath & Beyond during the first quarter worth about $30,000. Penserra Capital Management LLC purchased a new position in Bed Bath & Beyond during the first quarter worth about $30,000. Psagot Investment House Ltd. purchased a new position in Bed Bath & Beyond during the fourth quarter worth about $79,000. Finally, Parallel Advisors LLC boosted its holdings in Bed Bath & Beyond by 13.6% during the first quarter. Parallel Advisors LLC now owns 5,446 shares of the retailer’s stock worth $93,000 after purchasing an additional 653 shares during the last quarter. Institutional investors and hedge funds own 97.43% of the company’s stock.

About Bed Bath & Beyond

Bed Bath & Beyond Inc, together with its subsidiaries, operates a chain of retail stores. It sells a range of domestics merchandise, including bed linens and related items, bath items, and kitchen textiles; and home furnishings, such as kitchen and tabletop items, fine tabletop, basic housewares, general home furnishings, consumables, and various juvenile products.

Recommended Story: Is it better to buy a fund with a higher or lower NAV?

Analyst Recommendations for Bed Bath & Beyond (NASDAQ:BBBY)

Receive News & Ratings for Bed Bath & Beyond Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bed Bath & Beyond and related companies with MarketBeat.com's FREE daily email newsletter.